Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials von Kosorukov, V. S., Abuzarova, G. R., Zakharochkina, E. R., Gamzeleva, O. Yu, Yatsenko, K. A.

Volltext

Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins von A. V. Voronkov, O. Yu. Gamzeleva

Volltext

Selective opioid agonist Taphalgin® as a component of postoperative analgesia in various surgical areas: “NIKITA” observational multicenter study von Karelov, A. E., Ovezov, A. M., Zabolotskikh, I. B., Khoronenko, V. E., Abuzarova, G. R. , Musaeva, T. S., Klypa, T. V., Rodoman, G. V., Alexandrov, M. I., Bozhkova, S.  A., Boyarkov, A. V., Potapov, A. L., Shaimardanov, I.  V., Yemelyanov, D. V., Ilyin, S. A., Neduruyev, E. V., Shevchenko, N.  P., Solovyov, G. S., Sorokin, A. S., Gamzeleva, O. Yu, Kraevskaya, Yu. N.

Volltext